Retatrutide Developments: Future Outlook on Weight Loss Drug by 2026 | Retatrutide News

Retatrutide is being developed by Eli Lilly as a weight loss drug with updates projected for 2026. The drug is part of Eli Lilly's focus on GLP-1 agonis...
Market News · October 17, 2026